Codiak BioSciences (NASDAQ:CDAK) – Codiak announces price of $20
CAMBRIDGE, Mass., September 12, 2022 (GLOBE NEWSWIRE) — Codiak BioSciences, Inc. CDAK (“Codiak”), a clinical-stage biopharmaceutical company pioneering the development of exosome-based therapeutics as a